The latest closing stock price for VYNE Therapeutics as of February 21, 2025 is 2.74.
An investor who bought $1,000 worth of VYNE Therapeutics stock at the IPO in 2018 would have $-999 today, roughly -1 times their original investment - a -61.19% compound annual growth rate over 7 years.
The all-time high VYNE Therapeutics stock closing price was 2723.04 on March 28, 2018.
The VYNE Therapeutics 52-week high stock price is 4.30, which is 56.9% above the current share price.
The VYNE Therapeutics 52-week low stock price is 1.57, which is 42.7% below the current share price.
The average VYNE Therapeutics stock price for the last 52 weeks is 2.39.
An investor who bought $1,000 worth of VYNE Therapeutics stock at the IPO in 2018 would have $-999 today, roughly -1 times their original investment - a -61.19% compound annual growth rate over 7 years.
The all-time high VYNE Therapeutics stock closing price was 2723.04 on March 28, 2018.
The VYNE Therapeutics 52-week high stock price is 4.30, which is 56.9% above the current share price.
The VYNE Therapeutics 52-week low stock price is 1.57, which is 42.7% below the current share price.
The average VYNE Therapeutics stock price for the last 52 weeks is 2.39.